Posted by Clinical Lab Products | May 3, 2004 | Miscellaneous |
By Nicholas Borgert A conveyor track (above) delivers samples to various instruments at the Detroit Medical Center University Laboratories. Many have asked why clinical labs are not investing in more automation and robotic systems to offs
Read MorePosted by Clinical Lab Products | May 2, 2004 | Miscellaneous |
Difficulty in Diagnosing Crohn’s Disease Creates Need for More Precise Testing
Read MorePosted by Clinical Lab Products | Apr 4, 2004 | Cerebrovascular, Miscellaneous |
By Lisa Fratt Aspirin is the frontline therapy used to protect patients from cardiovascular disease and stroke. In the United States alone, 25 million to 30 million people take aspirin on a daily basis to prevent cardiovascular disease and strok
Read MorePosted by Clinical Lab Products | Apr 2, 2004 | Cancer, Cerebrovascular, Miscellaneous, Stroke |
By Renee DiIulio Proteomics will soon enable speedy, sensitive, specific diagnosis of ischemic stroke. This will result in rapid treatment and improved outcomes for patients. “The future, for the general physician, lies in genomics, or anal
Read MorePosted by Clinical Lab Products | Mar 10, 2004 | Miscellaneous |
Dade Behring Signs Manufacturing Licensing Agreement for FSAP Dade Behring and Aventis Behring LLC have signed a license agreement that provides Dade Behring with worldwide in vitro diagnostic rights to any Aventis Behring inventions that relate t
Read More